Chronic Heart Failure With Reduced Ejection Fraction clinical trials

Explore recruiting chronic heart failure with reduced ejection fraction clinical trials.

Recruiting chronic heart failure with reduced ejection fraction studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Chronic Heart Failure With Reduced Ejection Fraction trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Pivotal Phase 3 Randomized, Placebo-controlled Clinical Study to Evaluate the Efficacy and Safety of the sGC Stimulator Vericiguat/MK-1242 in Adults With Chronic Heart Failure With Reduced Ejection Fraction

Sweden, Spain, Hungary, Italy, Denmark, France +6 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Use of determination of drug levels to optimize pharmacotherapy of heart failure

Czechia

Therapeutic use (Phase IV) EU CTIS Study details

(21683) Phase 2b open-label clinical study to evaluate the tolerability and safety of an initiation dose of 5 mg of Vericiguat in participants with chronic heart failure with reduced ejection fraction

Spain, Italy, Sweden, Hungary, Poland

Therapeutic exploratory (Phase II) EU CTIS Study details

A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Dose Finding Study to Assess the Safety and Effectiveness of Tovinontrine in Patients With Chronic Heart Failure With Reduced Ejection Fraction

Italy, Czechia, Germany, Netherlands, Hungary, Belgium +6 more

Therapeutic exploratory (Phase II) EU CTIS Study details

Chronic Heart Failure With Reduced Ejection Fraction trials by city

Chronic Heart Failure With Reduced Ejection Fraction in Toronto Chronic Heart Failure With Reduced Ejection Fraction in Vancouver Chronic Heart Failure With Reduced Ejection Fraction in Montreal Chronic Heart Failure With Reduced Ejection Fraction in Calgary Chronic Heart Failure With Reduced Ejection Fraction in Edmonton Chronic Heart Failure With Reduced Ejection Fraction in Ottawa Chronic Heart Failure With Reduced Ejection Fraction in Winnipeg Chronic Heart Failure With Reduced Ejection Fraction in Quebec City Chronic Heart Failure With Reduced Ejection Fraction in Hamilton Chronic Heart Failure With Reduced Ejection Fraction in Kitchener Chronic Heart Failure With Reduced Ejection Fraction in London Chronic Heart Failure With Reduced Ejection Fraction in Halifax Chronic Heart Failure With Reduced Ejection Fraction in New York Chronic Heart Failure With Reduced Ejection Fraction in Los Angeles Chronic Heart Failure With Reduced Ejection Fraction in Chicago Chronic Heart Failure With Reduced Ejection Fraction in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease